Epiandrosterone and dehydroepiandrosterone affect glucose oxidation and interleukin-1β effects in pancreatic islets

Endocrinology

Volumn 137, Issue 8, 1996, Pages 3375-3385

  Laychock, Suzanne G ^a   Bauer, Amy L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIANDROSTERONE; PRASTERONE;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE OXIDATION; GLUCOSE UTILIZATION; GLYCOLYSIS; HYPERGLYCEMIA; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; TISSUE HOMOGENATE;

EID: 0029980935     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.8.8754764     Document Type: Article

References (47)

1. Coleman DL, Leiter EH, Schwizer RW 1982 Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31:830-833
2. Coleman DL, Schwizer RW, Leiter EH 1984 Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice. Diabetes 33:26-32
3. Schwartz AG, Whitcomb JM, Nyce JW, Lewbart ML, Pashko LL 1988 Dehydroepiandrosterone and structural analogs: a new class of cancer chemo-preventive agents. Adv Cancer Res 51:391-425
4. Mohan PF, Jacobson MS 1993 Inhibition of macrophage superoxide generation by dehydroepiandrosterone. Am J Med Sci 306:10-15
5. Lee TC, Lai GJ, Kao SL, Ho IC, Wu CW 1993 Protection of a rat tracheal epithelial cell line from paraquat toxicity by inhibition of glucose-6-phosphate dehydrogenase. Biochem Pharmacol 45:1143-1147
6. Liberato MH, Sonohara S, Brentani MM 1993 Effects of estrogens and proliferation and progesterone receptor levels in T470 human breast cancer cells. Tumor Biol 14:38-45
7. Rao MS, Ide H, Alvares K, Subbarao V, Reddy IK, Hecter O, Yeldandi AV 1993 Comparative effects of dehydroepiandrosterone and related steroids on peroxisome proliferation in rat liver. Life Sci 52:1709-1716
8. Southern C, Schulster D, Green IC 1990 Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 276:42-44
9. Welsh N, Eizirik DL, Bendtzen K, Sandier S 1991 Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129:3167-3173
10. Corbett JA, Wang JL, Hughes JH, Wolf BA, Sweetland MA, Lancaster Jr JR, McDaniel ML 1992 Nitric oxide and cyclic GMP formation induced by interleukin 1β in islets of Langerhans: evidence for a role of nitric oxide in islet dysfunction. Biochem J 287:229-235
11. Corbett JA, Sweetland MA, Wang JL, Lancaster Jr JR, McDaniel ML 1993 Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 90:1731-1735
12. Corbett JA, Lancaster Jr JR, Sweetland MA, McDaniel ML 1991 Interleukin-1β-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. J Biol Chem 266:21351-21354
13. Bredt DS, Snyder SH 1994 Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63:175-195
14. +-ATPase in glucose-desensitized rat islets. Diabetes 42:1392-1400
15. 2 and alpha 2-adrenoceptor agonists inhibit the pentose phosphate shunt in pancreatic islets. Arch Biochem Biophys 269:354-358
16. Ashcroft SJH, Hedeskov CJ, Randle PJ 1970 Glucose metabolism in mouse pancreatic islets. Biochem J 118:143-154
17. McDaniel ML, King S, Anderson S, Fink J, Lacy PE 1974 Effect of cytochalasin B on hexose transport and glucose metabolism in pancreatic islets. Diabetologia 10:303-308
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
19. 14 for the evaluation of the pathways of glucose metabolism. J Biol Chem 238:517-524
20. Ashcroft SJH, Weerasinghe LCC, Bassett JM, Randle PJ 1972 The pentose cycle and insulin release in mouse pancreatic islets. Biochem J 126:525-532
21. Laychock SG 1987 Effects of cyclic guanosine 3′,5′-monophosphate on glucose utilization in isolated islets of Langerhans. Endocrinology 120:517-524
22. 15N]nitrate in biological fluids. Anal Biochem 126:131-138
23. Cetkovic-Cvrlje M, Eizirik DL 1994 TNF-α and IFN-γ potentiate the deleterious effects of IL-1β on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6:399-406
24. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG 1993 Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233:119-125
25. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH 1986 Affinity-purified human interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 29:63-67
26. Zawalich WS, Diaz VA 1986 Interleukin 1 inhibits insulin secretion from isolated perifused rat islets. Diabetes 35:1119-1123
27. Spinas GA, Hansen BS, Linde S, Kastern W, Molvig J, Mandrup-Poulsen T, Dinarello CA, Nielsen JH, Nerup J 1987 Interleukin 1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans. Diabetologia 30:474-480
28. Sandler S, Andersson A, Hellerstrom C 1987 Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121:1424-1431
29. Suarez-Pinzon WL, Strynadka K, Schulz R, Rabinovitch A 1994 Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology 134:1006-1010
30. Ankarcrona M, Dypbukt JM, Brune B, Nicotera P 1994 Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 213:172-177
31. Corbett JA, Kwon G, Misko TP, Rodi CP, McDaniel ML 1994 Tyrosine kinase involvement in IL-1β-induced expression of iNOS by B-cells purified from islets of Langerhans. Am J Physiol 267:C48-C54
32. Corbett JA, McDaniel ML 1995 Intaislet release of interleukin 1 inhibits B cell function by inducing B cell expression of inducible nitric oxide synthase. J Exp Med 181:559-568
33. Saldeen J, Welsh N 1994 Interleukin-1β induced activation of NF-κB in insulin producing RINm5F cells is prevented by the protease inhibitor Na-p-tosyl-L-lysine chloromethylketone. Biochem Biophys Res Comm 203:149-155
34. Kwon G, Corbett JA, Rodi CP, Sullivan P, McDaniel ML 1995 Interleukin-1-β-induced nitric oxide synthase expression by rat pancreatic B-cells: evidence for the involvement of nuclear factor κB in the signaling mechanism. Endocrinology 136:4790-4795
35. Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF 1991 Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 88:7773-7777
36. Green LC, Delaney CA, Cunningham JM, Karmiris V, Southern C 1993 Interleukin-1β effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans-arginine-dependence and relationship to insulin secretion. Diabetologia 36:9-16
37. Gordon GB, Shantz LM, Talalay P 1987 Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone. Adv Enzyme Regul 26:355-382
38. Feher T, Bodrogi L, Feher KG, Poteczin E, Kolcsey IS 1977 Free and solvolysable dehydroepiandrosterone and androsterone in blood of mammals under physiological conditions and following administration of dehydroepiandrosterone. Acta Endocrinol (Copenh) 85:126-133
39. Aragno M, Tamagno E, Poli G, Boccuzzi G, Brignardello E, Danni O 1994 Prevention of carbon tetrachloride-induced lipid peroxidation in liver microsomes from dehydroepiandrosterone-pretreated rats. Free Rad Res 21:427-435
40. Nakashima N, Haji M, Sakai Y, Ono Y, Umeda F, Nawata H 1995 Effect of dehydroepiandrosterone on glucose uptake in cultured human fibroblasts. Metabolism 44:543-548
41. Coleman DL, Leiter EH, Applezweig N 1984 Therapeutic effects of dehydroepiandrosterone metabolites in diabetes mutant mice (C57BL/KsJ-db/db). Endocrinology 115:239-243
42. Sherman MP, Aeberhard EE, Wong VZ, Griscavage JM, Ignarro LJ 1993 Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biophys Res Commun 191:1301-1308
43. Corbett JA, McDaniel ML 1992 Does nitric oxide mediate autoimmune destruction of B-cells? Diabetes 41:897-903
44. Bedoya FJ, Flodstrom M, Eizirik DL 1995 Pyrrolidine dithiocarbamate prevents IL-1-induced nitric oxide synthase mRNA, but not superoxide dismutase mRNA, in insulin producing cells. Biochem Biophys Res Commun 210:816-822
45. Sandler S, Bendtzen K, Eizirik DL, Strandell E, Welsh M, Welsh N 1990 Metabolism and B-cell function of rat pancreatic islets exposed to human interleukin-1-β in the presence of a high glucose concentration. Immunol Lett 26:245-252
46. Cohen JD, Robins HI 1990 Cytotoxicity of diethylthiocarbamate in human vs. rodent cell lines. Invest New Drugs 8:137-142
47. Albina JE, Mastrofrancesco B 1993 Modulation of glucose metabolism in macrophages by products of nitric oxide synthase. Am J Physiol 264:C1594-C1599